Bernie Boylan

MCP is an active manager which adopts a return-driven investment strategy focused on predominantly pan-European buyout funds but with scope to invest in other areas of private equity. They may occasionally engage in shareholder activism. The firm seeks to invest, via their commitment to the Mithras Capital Fund, predominantly in European limited partnership buyout funds and in US-focused limited partnership buyout funds. They may use gearing to meet their investment objective and will ensure that the ratio of total consolidated assets (after deducting current liabilities) to total net debt is at least 3:1.

Bridge Valley Ventures invests in companies located in the UK, Europe and North America. The firm focuses on oncology, neuroscience, immunology and rare diseases therapeutics, pharma/biotech sector. They provide financing for buyout transaction.